폐암 환자의 우울에 대한 비약물적 중재의 효과: 체계적 문헌고찰 및 메타분석
Effects of Non-pharmacological Intervention on Depression among Patients with Lung Cancer: A Systematic Review and Meta-Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to examine the effects of non-pharmacological interventions (NPIs) on depression among patients with lung cancer. Methods: A systematic review and meta-analysis were conducted focusing on randomized controlled trials (RCTs) and quasi-experimental studies. A literature search was performed through PubMed, EMBASE, CINAHL, PsycINFO, Cochrane Library, and five Korean databases in November 2020. Data were analyzed using the Comprehensive Meta-Analysis Ver. 3.0 and Review Manager Ver. 5.4 programs. Results: A total of 37 studies, including 25 RCTs and 12 quasi-experimental studies, were identified; 27 studies reported data suitable for meta-analysis. In meta-analysis, the overall effect sizes for NPIs of RCTs and quasi-experimental studies were -0.61 (95% confidence interval (CI): -0.90, -0.31) and -0.40 (95% CI: -0.59, -0.21), respectively. Among the types of NPI in RCTs, the effect size of psychological therapy was the largest with -0.68 (95% CI: -1.13, -0.23). In addition, information & communication technology (ICT) had a larger effect size of -0.68 (95% CI: -1.13, -0.23), compared to face-toface intervention. Conclusion: NPIs may have a significant effect in reducing depressive symptoms in patients with lung cancer. It is suggested that further studies develop and apply structured NPIs considering intervention components such as type and mode of ICT delivery.
Abstract
Purpose: The purpose of this study was to examine the effects of non-pharmacological interventions (NPIs) on depression among patients with lung cancer. Methods: A systematic review and meta-analysis were conducted focusing on randomized controlled trials (RCTs) and quasi-experimental studies. A literature search was performed through PubMed, EMBASE, CINAHL, PsycINFO, Cochrane Library, and five Korean databases in November 2020. Data were analyzed using the Comprehensive Meta-Analysis Ver. 3.0 and Review Manager Ver. 5.4 programs. Results: A total of 37 studies, including 25 RCTs and 12 quasi-experimental studies, were identified; 27 studies reported data suitable for meta-analysis. In meta-analysis, the overall effect sizes for NPIs of RCTs and quasi-experimental studies were -0.61 (95% confidence interval (CI): -0.90, -0.31) and -0.40 (95% CI: -0.59, -0.21), respectively. Among the types of NPI in RCTs, the effect size of psychological therapy was the largest with -0.68 (95% CI: -1.13, -0.23). In addition, information & communication technology (ICT) had a larger effect size of -0.68 (95% CI: -1.13, -0.23), compared to face-toface intervention. Conclusion: NPIs may have a significant effect in reducing depressive symptoms in patients with lung cancer. It is suggested that further studies develop and apply structured NPIs considering intervention components such as type and mode of ICT delivery.
참고문헌 (29)
- "The number of cancer occurrences and cancer incidence by type of cancer, gender, and age in Korea"[URL]
- "The number of deaths and mortality rate by cause of death, gender, and age in Korea"[URL]
- Liao YC, "Symptoms, psychological distress, and supportive care needs in lung cancer patients", Support Care Cancer, 19, pp.1743~1751 (2011)
- Polanski J, "Quality of life of patients with lung cancer", Onco Targets Ther, 9, pp.1023~1028 (2016)
- Tan H, "The prevalence and related factors associated with psychosocial distress among 420 hospitalised lung cancer patients in China : a case study", Eur J Cancer Care(Engl), 28, pp.e13046~ (2019)
- Eichler M, "Psychological distress in lung cancer survivors at least 1 year after diagnosis-results of a German multicenter cross-sectional study", Psychooncology, 27, pp.2002~2008 (2018)
- 박보람, "The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea", PSYCHIATRY INVESTIGATION, 14(5), pp.618~625 (2017), 대한신경정신의학회[DOI]
- Walker J, "Prevalence, associations, and adequacy of treatment of major depression in patients with cancer : a cross-sectional analysis of routinely collected clinical data", Lancet Psychiatry, 1, pp.343~350 (2014)
- K. K. Shahedah, M.Med., "Depressive Symptoms in Newly Diagnosed Lung Carcinoma: Prevalence and Associated Risk Factors", Tuberculosis and Respiratory Diseases, 82(3), pp.217~226 (2019), 대한결핵및호흡기학회
- Hung MS, "Incidence and risk factors of depression after diagnosis of lung cancer: a nationwide population-based study", Medicine (Baltimore), 96, pp.e6864~ (2017)
- Smith HR, "Depression in cancer patients : pathogenesis, implications and treatment(review)", Oncol Lett, 9, pp.1509~1514 (2015)
- Wang YH, "Depression and anxiety in relation to cancer incidence and mortality : a systematic review and meta-analysis of cohort studies", Mol Psychiatry, 25, pp.1487~1499 (2020)
- 성경은, "폐암 환자의 항우울제 처방현황과 관련 요인 분석", 한국임상약학회지, 26(2), pp.107~114 (2016), 한국임상약학회
- Ostuzzi G, "Antidepressants for the treatment of depression in people with cancer", Cochrane Database Syst Rev, 4, pp.CD011006~ (2018)
- Walker J, "Treatment of depression in people with lung cancer : a systematic review", Lung Cancer, 79, pp.46~53 (2013)
- Hsieh CC, "The effects of supportive care interventions on depressive symptoms among patients with lung cancer : a metaanalysis of randomized controlled studies", Palliat Support Care, 15, pp.710~723 (2017)
- While A, "Nursing and information and communication technology(ICT) : a discussion of trends and future directions", Int J Nurs Stud, 48, pp.1302~1310 (2011)
- Hegerl U, "Promises and risks of web-based interventions in the treatment of depression", Dialogues Clin Neurosci, 22, pp.161~168 (2020)
- Ramos RM, "Validation of an mHealth app for depression screening and monitoring(psychologist in a pocket) : correlational study and concurrence analysis", JMIR Mhealth Uhealth, 7, pp.e12051~ (2019)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
- "JBI manual for evidence synthesis"[URL]
- Sterne JA, "RoB 2: a revised tool for assessing risk of bias in randomised trials", BMJ, 366, pp.l4898~ (2019)
- Statistical power analysis for the behavioral sciences, "Cohen J", Lawrence Erlbaum Associates, ~ (1988)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Coutiño-Escamilla L, "Non-pharmacological therapies for depressive symptoms in breast cancer patients : Systematic review and meta-analysis of randomized clinical trials", Breast, 44, pp.135~143 (2019)
- Okuyama T, "Psychotherapy for depression among advanced, incurable cancer patients : a systematic review and meta-analysis", Cancer Treat Rev, 56, pp.16~27 (2017)
- Chambers SK, "Psychological wellness and health-related stigma : a pilot study of an acceptance-focused cognitive behavioural intervention for people with lung cancer", Eur J Cancer Care(Engl), 24, pp.60~70 (2015)
- Faller H, "Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer : systematic review and meta-analysis", J Clin Oncol, 31, pp.782~793 (2013)
